Histogenics Corp (HSGX):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Histogenics Corp (HSGX) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C6594)・商品コード:DATA904C6594
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:45
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weight-bearing cartilage surface of the patient’s femur. It offers products which are used to repair knee cartilage damage. Histogenics provides regenerative medicine platform that combines bioadhesives, cell processing, scaffolding, tissue engineering and growth factors to provide solutions for cartilage injuries associated with bone loss and arthritis. It also offers a platform for tissue repair solutions. Histogenics is headquartered in Waltham, Massachusetts, the US.

Histogenics Corp (HSGX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogenics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogenics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Histogenics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Histogenics Raises US$10.3 Million In Venture Financing 10
Histogenics Raises US$49 Million In Series A Financing 11
Partnerships 13
Medinet Enters into Licensing Agreement with Histogenics 13
Histogenics Enters into Licensing Agreement with Advanced BioMatrix 14
Histogenics Enters into Licensing Agreement with Koken 15
Equity Offering 16
Histogenics Raises USD17 Million in Public Offering of Shares and Warrants 16
Histogenics Plans to Raise USD75 Million in Public Offering of Securities 18
Histogenics Raises USD6.3 Million in Public Offering of Shares 19
Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 20
Histogenics Raises USD30 Million in Private Placement of Shares, Series A Preferred Stock and Warrants 21
Histogenics Prices IPO for USD65 Million 22
Histogenics Corp – Key Competitors 24
Histogenics Corp – Key Employees 25
Histogenics Corp – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Aug 09, 2018: Histogenics announces second quarter 2018 financial and operating results 27
May 10, 2018: Histogenics Announces First Quarter 2018 Financial and Operating Results 29
Mar 15, 2018: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 30
Nov 09, 2017: Histogenics Announces Third Quarter 2017 Financial and Operating Results 33
Aug 10, 2017: Histogenics Announces Second Quarter 2017 Financial and Operating Results 34
May 11, 2017: Histogenics Announces First Quarter 2017 Financial and Operating Results 36
Mar 16, 2017: Histogenics Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016 37
Corporate Communications 39
Jul 31, 2018: Histogenics appoints E. Lynne Kelley, M.D., FACS as chief medical officer 39
Apr 18, 2018: Histogenics Appoints Susan Washer As Board Director 40
Oct 12, 2017: Histogenics Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer 41
Sep 18, 2017: Histogenics Announces Resignation of CMO 42
Jun 05, 2017: Histogenics Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer 43
May 15, 2017: Histogenics Receives Innovation Award 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Histogenics Corp, Medical Equipment, Key Facts, 2017 2
Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogenics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogenics Corp, Deals By Market, 2012 to YTD 2018 8
Histogenics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Histogenics Raises US$10.3 Million In Venture Financing 10
Histogenics Raises US$49 Million In Series A Financing 11
Medinet Enters into Licensing Agreement with Histogenics 13
Histogenics Enters into Licensing Agreement with Advanced BioMatrix 14
Histogenics Enters into Licensing Agreement with Koken 15
Histogenics Raises USD17 Million in Public Offering of Shares and Warrants 16
Histogenics Plans to Raise USD75 Million in Public Offering of Securities 18
Histogenics Raises USD6.3 Million in Public Offering of Shares 19
Histogenics Files Registration Statement for Public Offering of Shares to Raise USD50 Million 20
Histogenics Raises USD30 Million in Private Placement of Shares, Series A Preferred Stock and Warrants 21
Histogenics Prices IPO for USD65 Million 22
Histogenics Corp, Key Competitors 24
Histogenics Corp, Key Employees 25
Histogenics Corp, Subsidiaries 26

List of Figures
Histogenics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Histogenics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Histogenics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Histogenics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Histogenics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Histogenics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Histogenics Corp (HSGX):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C6594)販売に関する免責事項を必ずご確認ください。
★調査レポート[Histogenics Corp (HSGX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆